Next Article in Journal
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
Next Article in Special Issue
Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease
Previous Article in Journal / Special Issue
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Due to scheduled maintaince work on one of the switches in our server center, our websites www.mdpi.com and susy.mdpi.com may experience short service dirsuptions of up to 5 minutes on 30 January 2015 00:00 PM EST time.
Pharmaceuticals 2009, 2(3), 287-298; doi:10.3390/ph2030287

Notes on Article Versions

NoteDate
article html file updated18 January 2013 01:09 CET
article html file updated21 January 2013 18:59 CET
article html file updated25 January 2013 20:35 CET
article html file updated28 January 2013 18:01 CET
article html file updated5 February 2013 20:23 CET
article html file updated6 February 2013 16:15 CET
article xml file uploaded28 April 2014 10:59 CEST
article html file updated28 April 2014 10:59 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert